Clinical Challenge: Bruising, Bleeding Gums, Nosebleeds in Young College Athlete
A 21-year-old woman presents with complaints of easy bruising, bleeding gums, heavy periods, and nosebleeds. What is her diagnosis?
Hematology
Major Bleeding Linked to Anticoagulant Overdose in ICU Patients With COVID‑19
Findings from a retrospective chart review showed a need to carefully monitor inflammatory biomarkers and anticoagulant dosage in patients with severe COVID-19.
Model May Predict Postpartum Hemorrhage With Immune Thrombocytopenia
Researchers attempted to develop a predictive model for the risk of postpartum hemorrhage in patients who have ITP.
Quality of Life Improvement Is the Most Important Treatment Goal for Patients With Sickle Cell Disease
Researchers sought to determine what should be the primary treatment goal for patients with sickle cell disease.
CAR-T Cell Therapy Promising in Multiple Myeloma
Researchers sought to determine whether idecabtagene vicleucel, a CAR-T cell therapy, would be a viable treatment option in heavily pretreated patients with relapsed or refractory multiple myeloma.
Falsely Elevated HbA1c in a Patient With Euglycemia
Certain hemoglobin variants and conditions have been shown to affect red blood cell lifespan and hence may lead to false HbA1c results.
Mortality Trends in Patients With High-Risk Pulmonary Embolism
Although the mortality of patients with high-risk pulmonary embolism has decreased over time, the decrease cannot be attributed to improved treatments for pulmonary embolism.
Cognitive Behavioral Therapy Effective Strategy for Chronic Pain Management in Hemophilia
Nonpharmacologic treatment with cognitive-behavioral therapy combined with physiotherapy may be an effective pain management strategy for patients with severe hemophilia.
Transplant Beneficial for Kidney Failure in Sickle Cell
Patients with kidney failure who receive a kidney transplant, including those with sickle cell disease, have lower mortality.
COVID-19 Convalescent Plasma Shows Early Survival Benefit
Researchers assessed the effect of COVID-19 convalescent plasma on survival benefit at 7 and 14 days for patients hospitalized with the disease.
- Loading...
Loading...
Next post in Hematology Information Center
Loading... 
Loading...